First step: scientists test new blood disorder Drug's safety with common meds

This early-stage study aimed to understand how a potential new drug for myelofibrosis (a bone marrow disorder) interacts with other common medications that can speed up or slow down drug processing in the body. It involved 40 healthy volunteers who received single doses of the study drug alone and combined with other test medications. The main goals were to measure drug levels in the blood and check for safety issues when the drugs are taken together.